A Study of Genetic Profiling of Peyronie's Disease Patients

Overview

About this study

The purpose of this study is to provide comprehensive genetic profiling of Peyronie's Disease (PD) patients, discover candidate genes associated with the disease, and to compare the identified candidate genetic mutations/variations with familial and non-familial cases.

 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Men aged 45-70 years old (for initial screening); 
  • Diagnosis of Peyronie's Disease (PD); OR 
  • Male family members of men with PD (>18 years old).

Exclusion Criteria: 

  • None.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Landon Trost, M.D.

Open for enrollment

Contact information:

Tessa Kroeninger CCRP

(507)538-6107

Kroeninger.Tessa@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20455831

Mayo Clinic Footer